MAH

WuXi AppTec Partner Hutchison MediPharma Receives Approval of Fruquintinib Capsules in China

Shanghai, November 15, 2018: WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of Fruquintinib capsules (Elunate®) for metastatic…

6 years ago

WuXi STA first CDMO to support the approval of an innovative drug in China through the “MAH” pilot

WuXi STA enables Ascletis to receive NDA Approval from China FDA for Ganovo® Shanghai, June 15, 2018: STA Pharmaceutical Co., Ltd. (WuXi…

6 years ago

Internationalisation and regulatory reform driving growth and investment at CPhI China

2018 event prepares for surge in international attendees as MAH nears national rollout Amsterdam, May 18, 2018: CPhI & P-MEC China (#CPhIChina)…

6 years ago